Investors with a practical understanding of the biotechnology sector share an extraordinary opportunity; the chance to invest in the future. Granted, all investments are essentially an investment into the "future", but biotech takes that cliché and turns it into a tangible investment option. This is especially so in the case of small-cap, clinical stage companies, who have yet to see innovation transform into commercialization. For those companies, it is the prospect of bringing a product to market that keeps them going, and it is the likelihood of that happening that keeps investors on board. It is a delicate balance, and it is even further complicated by the very nature of the sector.
Clinical stage biotech's are not "normal" investments....
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|